US6395888B1
(en)
*
|
1996-02-01 |
2002-05-28 |
Gilead Sciences, Inc. |
High affinity nucleic acid ligands of complement system proteins
|
US5681811A
(en)
*
|
1993-05-10 |
1997-10-28 |
Protein Delivery, Inc. |
Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
|
KR100361933B1
(ko)
*
|
1993-09-08 |
2003-02-14 |
라 졸라 파마슈티칼 컴파니 |
화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
|
US5919455A
(en)
*
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
US5583114A
(en)
|
1994-07-27 |
1996-12-10 |
Minnesota Mining And Manufacturing Company |
Adhesive sealant composition
|
GB9425138D0
(en)
|
1994-12-12 |
1995-02-08 |
Dynal As |
Isolation of nucleic acid
|
US5932462A
(en)
*
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
TW517067B
(en)
*
|
1996-05-31 |
2003-01-11 |
Hoffmann La Roche |
Interferon conjugates
|
KR19990029749A
(ko)
*
|
1997-09-17 |
1999-04-26 |
미우라 아끼라 |
2가 반응성 수용성 고분자 유도체 및 이들을 함유하는 복합체
|
CA2302834A1
(en)
*
|
1997-09-18 |
1999-03-25 |
F. Hoffmann-La Roche Ag |
Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c
|
US6251382B1
(en)
|
1998-04-17 |
2001-06-26 |
Enzon, Inc. |
Biodegradable high molecular weight polymeric linkers and their conjugates
|
ES2251196T3
(es)
*
|
1998-06-08 |
2006-04-16 |
F. Hoffmann-La Roche Ag |
Uso de peg-ifn-alfa y ribavirina para el tratamiento de hepatitis c cronica.
|
WO2000008196A2
(en)
|
1998-08-06 |
2000-02-17 |
Duke University |
Urate oxidase
|
US6783965B1
(en)
|
2000-02-10 |
2004-08-31 |
Mountain View Pharmaceuticals, Inc. |
Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
|
US20060188971A1
(en)
*
|
1998-08-06 |
2006-08-24 |
Duke University |
Urate oxidase
|
PT1588716E
(pt)
*
|
1998-08-06 |
2011-05-25 |
Mountain View Pharmaceuticals |
Conjugados de peg-urato oxidase e sua utiliza??o
|
US6458953B1
(en)
*
|
1998-12-09 |
2002-10-01 |
La Jolla Pharmaceutical Company |
Valency platform molecules comprising carbamate linkages
|
CA2376057A1
(en)
*
|
1999-06-08 |
2000-12-14 |
La Jolla Pharmaceutical Company |
Valency platform molecules comprising aminooxy groups
|
US7169889B1
(en)
*
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
JO2291B1
(en)
|
1999-07-02 |
2005-09-12 |
اف . هوفمان لاروش ايه جي |
Erythropoietin derivatives
|
CZ299516B6
(cs)
*
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
CA2383794A1
(en)
*
|
1999-09-07 |
2001-03-15 |
Conjuchem Inc. |
Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents
|
DE60024101T2
(de)
|
1999-09-10 |
2006-07-27 |
The Procter & Gamble Company, Cincinnati |
Enzyminhibitoren
|
US6723788B1
(en)
|
1999-09-10 |
2004-04-20 |
The Procter & Gamble Company |
Enzyme inhibitors
|
US6713454B1
(en)
*
|
1999-09-13 |
2004-03-30 |
Nobex Corporation |
Prodrugs of etoposide and etoposide analogs
|
EP1229934B1
(de)
|
1999-10-01 |
2014-03-05 |
Immunogen, Inc. |
Zusammensetzungen und verfahren zur behandlung von krebs mittels immunkonjugaten und chemotherapeutischen agenzien
|
DE60139110D1
(de)
|
2000-01-10 |
2009-08-13 |
Maxygen Holdings Ltd |
G-csf konjugate
|
DK1257295T3
(da)
|
2000-02-11 |
2009-08-10 |
Bayer Healthcare Llc |
Faktor VII eller VIIA-lignende molekyler
|
US6756037B2
(en)
|
2000-03-31 |
2004-06-29 |
Enzon, Inc. |
Polymer conjugates of biologically active agents and extension moieties for facilitating conjugation of biologically active agents to polymeric terminal groups
|
US6777387B2
(en)
|
2000-03-31 |
2004-08-17 |
Enzon Pharmaceuticals, Inc. |
Terminally-branched polymeric linkers containing extension moieties and polymeric conjugates containing the same
|
US6586398B1
(en)
*
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
US6951939B2
(en)
|
2000-06-08 |
2005-10-04 |
La Jolla Pharmaceutical Company |
Multivalent platform molecules comprising high molecular weight polyethylene oxide
|
MXPA03000310A
(es)
*
|
2000-07-12 |
2004-12-13 |
Gryphon Therapeutics Inc |
Quimiocinas sinteticas bioactivas, modificadas con polimeros y metodos para su elaboracion y uso.
|
KR100396983B1
(ko)
*
|
2000-07-29 |
2003-09-02 |
이강춘 |
고반응성의 가지 달린 고분자 유도체 및 고분자와 단백질또는 펩타이드의 접합체
|
US7118737B2
(en)
*
|
2000-09-08 |
2006-10-10 |
Amylin Pharmaceuticals, Inc. |
Polymer-modified synthetic proteins
|
EP1318827A4
(de)
*
|
2000-09-08 |
2005-09-14 |
Gryphon Therapeutics Inc |
Durch polymere veränderte synthetische proteine
|
US7052686B2
(en)
*
|
2000-09-29 |
2006-05-30 |
Schering Corporation |
Pegylated interleukin-10
|
AU2002220002B2
(en)
|
2000-10-31 |
2006-12-14 |
Evonik Corporation |
Methods and compositions for enhanced delivery of bioactive molecules
|
US7083787B2
(en)
*
|
2000-11-15 |
2006-08-01 |
Globeimmune, Inc. |
Yeast-dendritic cell vaccines and uses thereof
|
CN1406131A
(zh)
*
|
2000-12-25 |
2003-03-26 |
株式会社资生堂 |
活化交感神经的香料组合物
|
US6350756B1
(en)
|
2001-01-18 |
2002-02-26 |
California Pacific Medical Center |
Camptothecin derivatives
|
CA2436623C
(en)
*
|
2001-01-30 |
2011-08-02 |
Kyowa Hakko Kogyo Co., Ltd. |
Branched polyalkylene glycols
|
JP2004532289A
(ja)
*
|
2001-02-20 |
2004-10-21 |
エンゾン ファーマシューティカルズ,インコーポレーテッド |
末端分枝高分子リンカーおよびそれを含む高分子複合体
|
DE60232434D1
(de)
|
2001-02-27 |
2009-07-09 |
Maxygen Aps |
Neue interferon-beta-ähnliche moleküle
|
US6403604B1
(en)
|
2001-03-01 |
2002-06-11 |
California Pacific Medical Center |
Nitrogen-based camptothecin derivatives
|
US6855720B2
(en)
|
2001-03-01 |
2005-02-15 |
California Pacific Medical Center |
Nitrogen-based camptothecin derivatives
|
ES2331562T3
(es)
*
|
2001-03-23 |
2010-01-08 |
Enzon, Inc. |
Profarmacos de agentes anticancerigenos que emplean acidos aromaticos sustituidos.
|
WO2002089830A1
(en)
*
|
2001-05-04 |
2002-11-14 |
North Carolina State University |
Polymer conjugates of insecticidal peptides or nucleic acids and methods of use thereof
|
US20030108585A1
(en)
*
|
2001-05-04 |
2003-06-12 |
Roe R. Michael |
Polymer conjugates of insecticidal peptides or nucleic acids or insecticides and methods of use thereof
|
US6828305B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6835802B2
(en)
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US6713452B2
(en)
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7713932B2
(en)
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US20040077835A1
(en)
*
|
2001-07-12 |
2004-04-22 |
Robin Offord |
Chemokine receptor modulators, production and use
|
KR100761652B1
(ko)
*
|
2001-08-25 |
2007-10-04 |
동아제약주식회사 |
단백질 또는 펩타이드에 결합되는 다가지의 고분자유도체와 접합체
|
US6913903B2
(en)
*
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7030082B2
(en)
*
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
US7312192B2
(en)
*
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
AU2004236174B2
(en)
|
2001-10-10 |
2011-06-02 |
Novo Nordisk A/S |
Glycopegylation methods and proteins/peptides produced by the methods
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
US8008252B2
(en)
|
2001-10-10 |
2011-08-30 |
Novo Nordisk A/S |
Factor VII: remodeling and glycoconjugation of Factor VII
|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
KR100508369B1
(ko)
*
|
2001-10-31 |
2005-08-17 |
주식회사 바이오폴리메드 |
펩타이드 스페이서를 갖는 생체적합성 고분자
|
MXPA04004336A
(es)
*
|
2001-11-07 |
2005-05-16 |
Nektar Therapeutics Al Corp |
Polimeros ramificados y sus conjugados.
|
ATE452654T1
(de)
*
|
2001-11-09 |
2010-01-15 |
Enzon Inc |
Polyalkylenoxid-konjugate von thiolhaltigen arzneistoffen
|
US20030171285A1
(en)
*
|
2001-11-20 |
2003-09-11 |
Finn Rory F. |
Chemically-modified human growth hormone conjugates
|
ATE439368T1
(de)
*
|
2001-12-19 |
2009-08-15 |
Univ Chicago |
Schnellreifende fluoreszierende proteine und verfahren zu deren anwendung
|
US8048408B2
(en)
|
2002-01-16 |
2011-11-01 |
Biocompatibles Uk Limited |
Polymer conjugates
|
CA2473376A1
(en)
|
2002-01-16 |
2003-07-31 |
Dynal Biotech Asa |
Method for isolating nucleic acids and protein from a single sample
|
KR100888371B1
(ko)
|
2002-01-17 |
2009-03-13 |
동아제약주식회사 |
가지 달린 고분자 유도체와 인터페론 결합체를 포함하는 항바이러스제
|
WO2003076490A1
(fr)
*
|
2002-03-13 |
2003-09-18 |
Beijing Jiankai Technology Co., Ltd. |
Derive polymere hydrophile a ramification de type y et procede de preparation d'un composite medical contenant le compose precite
|
US20050107310A1
(en)
*
|
2002-03-19 |
2005-05-19 |
Holick Michael F. |
Carboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof
|
US7557195B2
(en)
*
|
2002-03-20 |
2009-07-07 |
Biopolymed, Inc. |
Stoichiometric conjugates of biocompatible polymers at the unpaired cysteine residue of the wild-type G-CSF
|
AU2003241279A1
(en)
*
|
2002-03-26 |
2003-10-13 |
Biosynexus Incorporated |
Antimicrobial polymer conjugates
|
WO2003086312A2
(en)
*
|
2002-04-12 |
2003-10-23 |
A & D Bioscience, Inc. |
Conjugates comprising cancer cell specific ligands, a sugar and cancer chemotherapeutic agents/boron neutron capture therapy agents, and uses thereof
|
US20030215395A1
(en)
*
|
2002-05-14 |
2003-11-20 |
Lei Yu |
Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
|
ES2370710T3
(es)
*
|
2002-05-28 |
2011-12-22 |
Ucb Pharma, S.A. |
ISÓMERO POSICIONAL DE PEG DE UN ANTICUERPO ANTI-TNFalfa (CDP870).
|
US20040034050A1
(en)
*
|
2002-06-03 |
2004-02-19 |
Yang Li-Xi |
Homo-camptothecin derivatives
|
AU2003243380A1
(en)
*
|
2002-06-03 |
2003-12-19 |
California Pacific Medical Center |
Nitrogen-based homo-camptothecin derivatives
|
DE60336555D1
(de)
|
2002-06-21 |
2011-05-12 |
Novo Nordisk Healthcare Ag |
Pegylierte glykoformen von faktor vii
|
PL211175B1
(pl)
|
2002-06-21 |
2012-04-30 |
Novo Nordisk Healthcare Ag |
Koniugat polipeptydu czynnika VII, sposób wytwarzania takiego koniugatu, zawierający taki koniugat preparat farmaceutyczny oraz zastosowanie takiego koniugatu
|
US7122189B2
(en)
*
|
2002-08-13 |
2006-10-17 |
Enzon, Inc. |
Releasable polymeric conjugates based on aliphatic biodegradable linkers
|
US7413738B2
(en)
*
|
2002-08-13 |
2008-08-19 |
Enzon Pharmaceuticals, Inc. |
Releasable polymeric conjugates based on biodegradable linkers
|
US7087229B2
(en)
*
|
2003-05-30 |
2006-08-08 |
Enzon Pharmaceuticals, Inc. |
Releasable polymeric conjugates based on aliphatic biodegradable linkers
|
US20040247588A1
(en)
*
|
2002-08-28 |
2004-12-09 |
Johnson Robert E. |
Formulations of modified antibodies and methods of making the same
|
AU2003265361A1
(en)
*
|
2002-08-28 |
2004-03-19 |
Pharmacia Corporation |
Stable ph optimized formulation of a modified antibody
|
EP1591467A1
(de)
*
|
2002-09-09 |
2005-11-02 |
Nektar Therapeutics Al, Corporation |
Konjugat aus einem Polyethylene Glykol mit einer Alkanal Endgruppe und einem menschlichen Wachstumshormon
|
AP2005003249A0
(en)
|
2002-09-09 |
2005-03-31 |
Nektar Therapeutics Al Corp |
Water-soluble polymer alkanals.
|
US7556813B2
(en)
*
|
2002-09-27 |
2009-07-07 |
Trimeris, Inc. |
Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides
|
US8129330B2
(en)
*
|
2002-09-30 |
2012-03-06 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
US20040062748A1
(en)
*
|
2002-09-30 |
2004-04-01 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
PA8588901A1
(es)
*
|
2002-11-20 |
2005-02-04 |
Pharmacia Corp |
Conjugados de hormona de crecimiento humana pegilados n-terminales y proceso para su preparacion
|
GB0229287D0
(en)
*
|
2002-12-16 |
2003-01-22 |
Dna Res Innovations Ltd |
Polyfunctional reagents
|
CA2511815A1
(en)
*
|
2002-12-26 |
2004-07-22 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity
|
NZ541124A
(en)
*
|
2002-12-26 |
2008-08-29 |
Mountain View Pharmaceuticals |
Polymer conjugates of interferon-beta with enhanced biological potency
|
EP1616003A4
(de)
*
|
2002-12-30 |
2007-06-20 |
Gryphon Therapeutics Inc |
Wasserlösliche thioester- und selenoesterverbindungen sowie verfahren zur herstellung und verwendung davon
|
US20060014248A1
(en)
*
|
2003-01-06 |
2006-01-19 |
Xencor, Inc. |
TNF super family members with altered immunogenicity
|
US7553930B2
(en)
*
|
2003-01-06 |
2009-06-30 |
Xencor, Inc. |
BAFF variants and methods thereof
|
US20050221443A1
(en)
*
|
2003-01-06 |
2005-10-06 |
Xencor, Inc. |
Tumor necrosis factor super family agonists
|
US20050130892A1
(en)
*
|
2003-03-07 |
2005-06-16 |
Xencor, Inc. |
BAFF variants and methods thereof
|
US20070269891A9
(en)
*
|
2003-01-13 |
2007-11-22 |
Yasunobu Tanaka |
Solid surface with immobilized degradable cationic polymer for transfecting eukaryotic cells
|
US20040138154A1
(en)
*
|
2003-01-13 |
2004-07-15 |
Lei Yu |
Solid surface for biomolecule delivery and high-throughput assay
|
GB0301014D0
(en)
*
|
2003-01-16 |
2003-02-19 |
Biocompatibles Ltd |
Conjugation reactions
|
US20090123367A1
(en)
*
|
2003-03-05 |
2009-05-14 |
Delfmems |
Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases
|
AU2004218354B2
(en)
*
|
2003-03-05 |
2009-10-01 |
Halozyme, Inc. |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
|
US7871607B2
(en)
*
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
US20060104968A1
(en)
*
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
CA2519092C
(en)
|
2003-03-14 |
2014-08-05 |
Neose Technologies, Inc. |
Branched water-soluble polymers and their conjugates
|
US7332164B2
(en)
*
|
2003-03-21 |
2008-02-19 |
Enzon Pharmaceuticals, Inc. |
Heterobifunctional polymeric bioconjugates
|
US7642340B2
(en)
|
2003-03-31 |
2010-01-05 |
Xencor, Inc. |
PEGylated TNF-α variant proteins
|
US7610156B2
(en)
*
|
2003-03-31 |
2009-10-27 |
Xencor, Inc. |
Methods for rational pegylation of proteins
|
AU2004227937B2
(en)
*
|
2003-03-31 |
2007-09-20 |
Xencor, Inc |
Methods for rational pegylation of proteins
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
CA2521381C
(en)
|
2003-04-11 |
2020-05-26 |
Kenneth Hinds |
Method for preparation of site-specific protein conjugates
|
WO2004091517A2
(en)
|
2003-04-15 |
2004-10-28 |
Smithkline Beecham Corporation |
Conjugates comprising human il-18 and substitution mutants thereof
|
US7189694B2
(en)
*
|
2003-04-18 |
2007-03-13 |
University Of Florida Research Foundation, Inc. |
Inhibitors of autophosphorylation protein kinases
|
ES2380093T3
(es)
|
2003-05-09 |
2012-05-08 |
Biogenerix Ag |
Composiciones y métodos para la preparación de mutantes de glucosilación de la hormona del crecimiento humana
|
MXPA05012315A
(es)
*
|
2003-05-12 |
2006-04-18 |
Affymax Inc |
Compuestos poli(etilenglicol) modificados novedosos y usos de los mismos.
|
KR101227666B1
(ko)
*
|
2003-05-12 |
2013-01-31 |
아피맥스, 인크. |
에리스로포이에틴 수용체에 결합하는 펩티드
|
OA13164A
(en)
*
|
2003-05-12 |
2006-12-13 |
Affymax Inc |
Novel peptides that bind to the erythropoietin receptor.
|
WO2004100997A2
(en)
*
|
2003-05-12 |
2004-11-25 |
Affymax, Inc. |
Spacer moiety for poly(ethylene glycol) -modified peptides
|
US7947261B2
(en)
*
|
2003-05-23 |
2011-05-24 |
Nektar Therapeutics |
Conjugates formed from polymer derivatives having particular atom arrangements
|
ES2725808T3
(es)
*
|
2003-05-23 |
2019-09-27 |
Nektar Therapeutics |
Derivados de PEG que contienen dos cadenas de PEG
|
AR047552A1
(es)
|
2003-06-26 |
2006-01-25 |
Control Delivery Sys Inc |
Sistemas de suministro de farmacos de liberacion sostenida biodegradables
|
US20050048123A1
(en)
|
2003-06-26 |
2005-03-03 |
Control Delivery System, Inc. |
In situ gelling drug delivery system
|
WO2005012484A2
(en)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Antibody-toxin conjugates
|
PT1660047E
(pt)
|
2003-08-13 |
2014-02-27 |
Biocon Ltd |
Formulação de dosagem sólida de sais de ácidos gordos em micropartículas para agentes terapêuticos
|
EP3168304A1
(de)
*
|
2003-08-27 |
2017-05-17 |
Ophthotech Corporation |
Kombinationstherapie zur behandlung neovaskulärer erkrankungen
|
US8394365B2
(en)
|
2003-09-17 |
2013-03-12 |
Nektar Therapeutics |
Multi-arm polymer prodrugs
|
PL1675622T3
(pl)
|
2003-09-17 |
2017-11-30 |
Nektar Therapeutics |
Proleki na bazie wieloramiennego polimeru
|
WO2005035565A1
(en)
|
2003-10-10 |
2005-04-21 |
Novo Nordisk A/S |
Il-21 derivatives
|
EP1675871A2
(de)
|
2003-10-10 |
2006-07-05 |
Xencor Inc. |
Tnf-alpha-varianten auf proteinbasis zur behandlung von erkrankungen in verbindung mit tnf-alpha
|
ES2428358T3
(es)
|
2003-10-17 |
2013-11-07 |
Novo Nordisk A/S |
Terapia de combinación
|
US20050214250A1
(en)
|
2003-11-06 |
2005-09-29 |
Harris J M |
Method of preparing carboxylic acid functionalized polymers
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
ES2445948T3
(es)
*
|
2003-11-24 |
2014-03-06 |
Ratiopharm Gmbh |
Eritropoyetina glicopegilada
|
US7842661B2
(en)
|
2003-11-24 |
2010-11-30 |
Novo Nordisk A/S |
Glycopegylated erythropoietin formulations
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
US20060040856A1
(en)
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
JP2007515410A
(ja)
*
|
2003-12-03 |
2007-06-14 |
ネオス テクノロジーズ インコーポレイテッド |
GlycoPEG化卵胞刺激ホルモン
|
US7956032B2
(en)
|
2003-12-03 |
2011-06-07 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
EP1711825A4
(de)
*
|
2004-01-07 |
2008-01-23 |
Ambit Biosciences Corp |
Konjugierte kleine moleküle
|
CN101072789B
(zh)
|
2004-01-08 |
2013-05-15 |
生物种属学股份公司 |
肽的o-连接的糖基化
|
US20070105770A1
(en)
*
|
2004-01-21 |
2007-05-10 |
Novo Nordisk A/S |
Transglutaminase mediated conjugation of peptides
|
EP1720892B1
(de)
*
|
2004-01-26 |
2013-07-24 |
BioGeneriX AG |
Mit verzweigten Polymeren modifizierte Zucker und Nukleotide
|
CN1925871A
(zh)
*
|
2004-01-27 |
2007-03-07 |
南加州大学 |
聚合物结合的抗体癌症治疗剂
|
AU2005319099B2
(en)
|
2004-02-02 |
2010-09-16 |
Ambrx, Inc. |
Modified human growth hormone
|
WO2005074524A2
(en)
|
2004-02-02 |
2005-08-18 |
Ambrx, Inc. |
Modified human interferon polypeptides and their uses
|
US7803931B2
(en)
|
2004-02-12 |
2010-09-28 |
Archemix Corp. |
Aptamer therapeutics useful in the treatment of complement-related disorders
|
WO2005084303A2
(en)
*
|
2004-03-01 |
2005-09-15 |
Enzon Pharmaceuticals, Inc. |
Interferon-beta polymer conjugates
|
WO2005107815A2
(en)
*
|
2004-05-03 |
2005-11-17 |
Nektar Therapeutics Al, Corporation |
Polymer derivatives comprising an imide branching point
|
KR101699142B1
(ko)
|
2004-06-18 |
2017-01-23 |
암브룩스, 인코포레이티드 |
신규 항원-결합 폴리펩티드 및 이의 용도
|
WO2006005058A2
(en)
*
|
2004-06-30 |
2006-01-12 |
Nektar Therapeutics Al, Corporation |
Polymer-factor ix moiety conjugates
|
AU2014280936B2
(en)
*
|
2004-06-30 |
2016-12-15 |
Nektar Therapeutics |
Polymer-factor ix moiety conjugates
|
WO2006010143A2
(en)
|
2004-07-13 |
2006-01-26 |
Neose Technologies, Inc. |
Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
|
ES2618028T3
(es)
|
2004-07-19 |
2017-06-20 |
Biocon Limited |
Conjugados insulina-oligómero, formulaciones y usos de éstos.
|
US7618615B2
(en)
|
2004-08-13 |
2009-11-17 |
Healthpartners Research Foundation |
Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia
|
US9216161B2
(en)
|
2004-08-13 |
2015-12-22 |
Healthpartners Research Foundation |
Methods of treating Huntington's disease comprising administering metal chelators to the upper one-third of the nasal cavity
|
EP1799249A2
(de)
|
2004-09-10 |
2007-06-27 |
Neose Technologies, Inc. |
Glycopegyliertes interferon alpha
|
US7358223B2
(en)
*
|
2004-10-04 |
2008-04-15 |
Nitto Denko Corporation |
Biodegradable cationic polymers
|
EP1814573B1
(de)
|
2004-10-29 |
2016-03-09 |
ratiopharm GmbH |
Remodellierung und glykopegylierung von fibroblasten-wachstumsfaktor (fgf)
|
EA200700990A1
(ru)
*
|
2004-11-11 |
2008-04-28 |
Афимакс, Инк. |
Новые пептиды, которые связывают рецептор эритропоэтина
|
WO2006062685A2
(en)
*
|
2004-11-11 |
2006-06-15 |
Affymax, Inc. |
Novel peptides that bind to the erythropoietin receptor
|
JP4990792B2
(ja)
|
2004-12-22 |
2012-08-01 |
アンブレツクス・インコーポレイテツド |
アミノアシル−tRNAシンテターゼの組成物およびこの使用
|
CN103290084A
(zh)
|
2004-12-22 |
2013-09-11 |
Ambrx公司 |
表达和纯化重组人类生长激素的方法
|
MX2007007587A
(es)
|
2004-12-22 |
2007-12-11 |
Ambrx Inc |
Formulaciones de la hormona del crecimiento humano que comprenden un aminoacido codificado de manera no natural.
|
BRPI0519562A2
(pt)
*
|
2004-12-27 |
2009-01-27 |
Baxter Int |
construÇço proteinÁcea, complexo, mÉtodo para prolongar a meia-vida in vivo de fator viii (fviii) ou um derivado biologicamente ativo do mesmo composiÇço farmacÊutica, e, mÉtodo para formar uma construÇço proteinÁcea
|
NZ556436A
(en)
*
|
2005-01-10 |
2010-11-26 |
Biogenerix Ag |
Glycopegylated granulocyte colony stimulating factor
|
US7365127B2
(en)
|
2005-02-04 |
2008-04-29 |
Enzon Pharmaceuticals, Inc. |
Process for the preparation of polymer conjugates
|
US20080268013A1
(en)
*
|
2005-02-10 |
2008-10-30 |
Emory University |
Polyethylene Oxide Polymers Including Anti-Inflammatory Glycodendrons
|
US20060233740A1
(en)
*
|
2005-03-23 |
2006-10-19 |
Bossard Mary J |
Conjugates of an hGH moiety and a polymer
|
EP1868652A2
(de)
|
2005-04-05 |
2007-12-26 |
Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. |
Verfahren zur abschirmung von funktionalen stellen oder epitopen auf proteinen
|
US9187546B2
(en)
|
2005-04-08 |
2015-11-17 |
Novo Nordisk A/S |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
JP2008535500A
(ja)
|
2005-04-11 |
2008-09-04 |
サビエント ファーマセウティカルズ インク. |
変異型尿酸オキシダーゼおよびその利用
|
US8148123B2
(en)
*
|
2005-04-11 |
2012-04-03 |
Savient Pharmaceuticals, Inc. |
Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
|
US20080159976A1
(en)
*
|
2005-04-11 |
2008-07-03 |
Jacob Hartman |
Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
|
US7811800B2
(en)
|
2005-04-11 |
2010-10-12 |
Savient Pharmaceuticals, Inc. |
Variant form of urate oxidase and use thereof
|
US7833979B2
(en)
*
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
US20090081122A1
(en)
*
|
2005-05-23 |
2009-03-26 |
Universite De Geneve |
Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
|
JP5216580B2
(ja)
|
2005-05-25 |
2013-06-19 |
ノヴォ ノルディスク アー/エス |
グリコペグ化第ix因子
|
US8324159B2
(en)
*
|
2005-06-03 |
2012-12-04 |
Affymax, Inc. |
Erythropoietin receptor peptide formulations and uses
|
JP2008541769A
(ja)
|
2005-06-03 |
2008-11-27 |
アンブレツクス・インコーポレイテツド |
改善されたヒトインターフェロン分子及びそれらの使用
|
US7919461B2
(en)
|
2005-06-03 |
2011-04-05 |
Affymax, Inc. |
Erythropoietin receptor peptide formulations and uses
|
US7550433B2
(en)
*
|
2005-06-03 |
2009-06-23 |
Affymax, Inc. |
Erythropoietin receptor peptide formulations and uses
|
CA2611836A1
(en)
*
|
2005-06-13 |
2006-12-21 |
Nastech Pharmaceutical Company Inc. |
Transmucosal delivery of peptide derivatives
|
ES2553160T3
(es)
|
2005-06-17 |
2015-12-04 |
Novo Nordisk Health Care Ag |
Reducción y derivatización selectivas de proteínas Factor VII transformadas por ingeniería que comprenden al menos una cisteína no nativa
|
JP2008543943A
(ja)
*
|
2005-06-20 |
2008-12-04 |
ペプゲン コーポレイション |
ヒトインターフェロンアルファ類似体とインターフェロンタウの低毒性長期循環性キメラ
|
US7695710B2
(en)
*
|
2005-06-20 |
2010-04-13 |
Pepgen Corporation |
Antitumor and antiviral combination therapies using low-toxicity, long-circulating human interferon-alpha analogs
|
EP1926768B1
(de)
|
2005-07-18 |
2011-09-14 |
Nektar Therapeutics |
Verzweigte funktionalisierte polymere unter verwendung von verzweigten polyolen als kernen
|
KR100735784B1
(ko)
*
|
2005-07-20 |
2007-07-06 |
재단법인 목암생명공학연구소 |
인간 과립구콜로니자극인자 변이체 및 이의 화학적 접합물
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
JP4808453B2
(ja)
*
|
2005-08-26 |
2011-11-02 |
株式会社荏原製作所 |
研磨方法及び研磨装置
|
WO2007025988A2
(en)
*
|
2005-08-30 |
2007-03-08 |
Novo Nordisk Health Care Ag |
Liquid formulations of pegylated growth hormone
|
US7875602B2
(en)
*
|
2005-10-21 |
2011-01-25 |
Sutter West Bay Hospitals |
Camptothecin derivatives as chemoradiosensitizing agents
|
US20090048440A1
(en)
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
CA2626522A1
(en)
|
2005-11-16 |
2007-05-24 |
Ambrx, Inc. |
Methods and compositions comprising non-natural amino acids
|
US7811555B2
(en)
*
|
2005-12-30 |
2010-10-12 |
Cordis Corporation |
Tri-branched biologically active copolymer
|
US8133707B2
(en)
*
|
2006-01-17 |
2012-03-13 |
Enzon Pharmaceuticals, Inc. |
Methods of preparing activated polymers having alpha nitrogen groups
|
CN101400363B
(zh)
|
2006-01-18 |
2012-08-29 |
昌达生物科技公司 |
具有增强的稳定性的药物组合物
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US7671067B2
(en)
|
2006-02-09 |
2010-03-02 |
Enzon Pharmaceuticals, Inc. |
Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin
|
US7462627B2
(en)
|
2006-02-09 |
2008-12-09 |
Enzon Pharmaceuticals, Inc. |
Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
|
JP2009528430A
(ja)
*
|
2006-02-28 |
2009-08-06 |
ダウ グローバル テクノロジーズ インコーポレイティド |
ポリエチレングリコールカーボネートの製造方法
|
HUE026496T2
(en)
|
2006-03-08 |
2016-06-28 |
Archemix Llc |
Complement-binding aptamers and anti-C5 agents for treating eye diseases
|
KR20080108147A
(ko)
|
2006-03-31 |
2008-12-11 |
백스터 인터내셔널 인코포레이티드 |
페질화된 인자 viii
|
US7645860B2
(en)
|
2006-03-31 |
2010-01-12 |
Baxter Healthcare S.A. |
Factor VIII polymer conjugates
|
US7700541B2
(en)
*
|
2006-04-06 |
2010-04-20 |
Nitto Denko Corporation |
Biodegradable cationic polymers
|
CN101622270B
(zh)
*
|
2006-04-12 |
2014-01-01 |
萨文特医药公司 |
用阳离子表面活性剂纯化蛋白质的方法
|
US20080096819A1
(en)
*
|
2006-05-02 |
2008-04-24 |
Allozyne, Inc. |
Amino acid substituted molecules
|
CA2653748A1
(en)
|
2006-05-02 |
2007-11-15 |
Allozyne, Inc. |
Non-natural amino acid substituted polypeptides
|
CN101484576A
(zh)
|
2006-05-24 |
2009-07-15 |
诺沃-诺迪斯克保健股份有限公司 |
具有延长的体内半寿期的因子ix类似物
|
JP2009539879A
(ja)
*
|
2006-06-09 |
2009-11-19 |
エンゾン ファーマスーティカルズ インコーポレイテッド |
インデノイソキノリン放出性ポリマー複合体
|
HUE025738T2
(en)
*
|
2006-06-30 |
2016-04-28 |
Sigma-Tau Pharma Ltd |
Recombinant host for L-asparaginase II production
|
EP2040757A2
(de)
*
|
2006-07-07 |
2009-04-01 |
Novo Nordisk Health Care AG |
Neue proteinkonjugate und herstellungsverfahren
|
JP2009544327A
(ja)
|
2006-07-21 |
2009-12-17 |
ノヴォ ノルディスク アー/エス |
O−結合型グリコシル化配列によるペプチドのグリコシル化
|
JP5399906B2
(ja)
|
2006-09-08 |
2014-01-29 |
アンブルックス,インコーポレイテッド |
脊椎動物細胞用のハイブリッドサプレッサーtrna
|
CN101511856B
(zh)
|
2006-09-08 |
2016-01-20 |
Ambrx公司 |
脊椎动物细胞中抑制因子trna的转录
|
CN106008699A
(zh)
|
2006-09-08 |
2016-10-12 |
Ambrx公司 |
经修饰的人类血浆多肽或Fc骨架和其用途
|
US7985783B2
(en)
|
2006-09-21 |
2011-07-26 |
The Regents Of The University Of California |
Aldehyde tags, uses thereof in site-specific protein modification
|
EP2821078B1
(de)
|
2006-09-28 |
2016-09-21 |
Merck Sharp & Dohme Corp. |
Pegylieretes il-10 zur verwendung zur behandlung von lymphom
|
JP2010505874A
(ja)
|
2006-10-03 |
2010-02-25 |
ノヴォ ノルディスク アー/エス |
ポリペプチドコンジュゲートの精製方法
|
LT2068907T
(lt)
|
2006-10-04 |
2018-01-10 |
Novo Nordisk A/S |
Glicerolio sujungti pegilinti sacharidai ir glikopeptidai
|
US20090252703A1
(en)
*
|
2006-10-19 |
2009-10-08 |
Gegg Jr Colin V |
Use of alcohol co-solvents to improve pegylation reaction yields
|
AU2007343796A1
(en)
*
|
2006-10-25 |
2008-07-24 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
DE602007005165D1
(de)
*
|
2006-11-07 |
2010-04-15 |
Dsm Ip Assets Bv |
Carbamat, thiocarbamat oder carbamid mit einer biomolekularen gruppierung
|
CN101125207B
(zh)
*
|
2006-11-14 |
2012-09-05 |
上海华谊生物技术有限公司 |
带有聚乙二醇基团的艾塞丁或其类似物及其制剂和用途
|
KR101441709B1
(ko)
|
2006-11-30 |
2014-09-18 |
넥타르 테라퓨틱스 |
중합체 컨쥬게이트의 제조 방법
|
KR101503085B1
(ko)
|
2006-12-27 |
2015-03-16 |
넥타르 테라퓨틱스 |
방출가능한 연결을 갖는 폰 빌레브란드 인자 및 인자 ⅷ폴리머 컨주게이트
|
BRPI0720619B1
(pt)
*
|
2006-12-27 |
2022-04-05 |
Nektar Therapeutics |
Composto de fator ix-poli(etileno glicol) com uma ligação liberável, método para preparar o mesmo e composição
|
US20080159964A1
(en)
*
|
2006-12-29 |
2008-07-03 |
Enzon Pharmaceuticals, Inc. |
Use of adenosine deaminase for treating pulmonary disease
|
EP2125014A2
(de)
|
2007-01-16 |
2009-12-02 |
Enzon Pharmaceuticals, Inc. |
Posaconazol-polymer-konjugate und behandlungsverfahren mithilfe von posaconazol und polymer-konjugaten davon
|
WO2008095004A2
(en)
*
|
2007-01-31 |
2008-08-07 |
Affymax, Inc. |
Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
|
WO2008095182A2
(en)
*
|
2007-02-01 |
2008-08-07 |
National Research Council Of Canada |
Formulations of lipophilic bioactive molecules
|
KR20090108082A
(ko)
|
2007-02-09 |
2009-10-14 |
엔존 파마슈티컬즈, 인코포레이티드 |
7-에틸-10-하이드록시캄토테신 다분지형 고분자 접합체를 이용한 내성 또는 불응성 암의 치료방법
|
CN107501407B
(zh)
|
2007-03-30 |
2022-03-18 |
Ambrx公司 |
经修饰fgf-21多肽和其用途
|
KR20150064246A
(ko)
|
2007-04-03 |
2015-06-10 |
바이오제너릭스 게엠베하 |
글리코페길화 g―csf를 이용하는 치료 방법
|
BRPI0810384B8
(pt)
*
|
2007-04-20 |
2021-05-25 |
Defiante Farm S A |
terapia enzimática anticâncer
|
JP5511653B2
(ja)
|
2007-04-20 |
2014-06-04 |
シグマ−タウ レア ディジージズ エスィアー |
安定な組換えアデノシン・デアミナーゼ
|
AU2008247815B2
(en)
|
2007-05-02 |
2012-09-06 |
Ambrx, Inc. |
Modified interferon beta polypeptides and their uses
|
WO2008153745A2
(en)
|
2007-05-22 |
2008-12-18 |
Amgen Inc. |
Compositions and methods for producing bioactive fusion proteins
|
US20080312174A1
(en)
*
|
2007-06-05 |
2008-12-18 |
Nitto Denko Corporation |
Water soluble crosslinked polymers
|
US9707274B2
(en)
|
2007-06-08 |
2017-07-18 |
Healthpartners Research & Education |
Methods for preventing and treating post-traumatic stress disorder (PTSD)
|
JP5876649B2
(ja)
|
2007-06-12 |
2016-03-02 |
ラツィオファルム ゲーエムベーハーratiopharm GmbH |
ヌクレオチド糖の改良製造法
|
US20090016985A1
(en)
*
|
2007-07-11 |
2009-01-15 |
Enzon Pharmaceuticals, Inc. |
Polymeric drug delivery system containing a multi-substituted aromatic moiety
|
CL2008002399A1
(es)
*
|
2007-08-16 |
2009-01-02 |
Pharmaessentia Corp |
Conjugado sustancialmente puro que posee una porcion polimerica, una porcion proteica (interferon alfa 2b) y un ligante alifatico de 1 a 10 atomos de carbono, util en el tratamiento de las hepatitis b o c.
|
CA2707840A1
(en)
*
|
2007-08-20 |
2009-02-26 |
Allozyne, Inc. |
Amino acid substituted molecules
|
US8207112B2
(en)
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|
AU2008313248B2
(en)
|
2007-10-16 |
2012-04-26 |
Biocon Limited |
An orally administerable solid pharmaceutical composition and a process thereof
|
NZ603812A
(en)
|
2007-11-20 |
2014-06-27 |
Ambrx Inc |
Modified insulin polypeptides and their uses
|
NZ620606A
(en)
|
2008-02-08 |
2015-08-28 |
Ambrx Inc |
Modified leptin polypeptides and their uses
|
CN103497246B
(zh)
|
2008-02-27 |
2016-08-10 |
诺沃—诺迪斯克有限公司 |
缀合的因子viii分子
|
TWI395593B
(zh)
|
2008-03-06 |
2013-05-11 |
Halozyme Inc |
可活化的基質降解酵素之活體內暫時性控制
|
CA3096629A1
(en)
|
2008-04-14 |
2009-10-22 |
Halozyme, Inc. |
Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
|
TWI394580B
(zh)
|
2008-04-28 |
2013-05-01 |
Halozyme Inc |
超快起作用胰島素組成物
|
US8476404B1
(en)
*
|
2008-07-04 |
2013-07-02 |
Bhalchandra Shripad Lele |
Selectively functionalized polyhydric compounds
|
CA2729943A1
(en)
|
2008-07-08 |
2010-01-14 |
Board Of Regents, The University Of Texas System |
Novel inhibitors of proliferation and activation of signal transducer and activator of transcription (stats)
|
PE20110426A1
(es)
|
2008-07-23 |
2011-07-01 |
Ambrx Inc |
Polipeptidos g-csf bovinos modificados
|
UA104146C2
(ru)
*
|
2008-07-31 |
2014-01-10 |
Фармаиссеншиа Корп. |
ПОЛИМЕРНЫЕ КОНЪЮГАТЫ ФРАГМЕНТОВ ИНТЕРФЕРОНА-β, ЭРИТРОПОЭТИНА И ГОРМОНА РОСТА
|
MX2011001583A
(es)
|
2008-08-11 |
2011-04-04 |
Nektar Therapeutics |
Conjugados de alcanoato polimericos de multiples brazos.
|
EP2157432A1
(de)
*
|
2008-08-15 |
2010-02-24 |
Qiagen GmbH |
Verfahren zur Analyse einer komplexen Probe durch Massenspektrometrie
|
ES2744975T3
(es)
|
2008-09-23 |
2020-02-27 |
Nektar Therapeutics |
Método de dosificación metronómica con profármacos de camptotecina (p. ej. PEG-Irinotecán)
|
CN102224238B
(zh)
|
2008-09-26 |
2015-06-10 |
Ambrx公司 |
非天然氨基酸复制依赖性微生物和疫苗
|
CN107022020A
(zh)
|
2008-09-26 |
2017-08-08 |
Ambrx公司 |
修饰的动物促红细胞生成素多肽和其用途
|
SG172064A1
(en)
|
2008-12-09 |
2011-07-28 |
Halozyme Inc |
Extended soluble ph20 polypeptides and uses thereof
|
AU2009333325B2
(en)
|
2008-12-17 |
2014-07-10 |
Merck Sharp & Dohme Corp. |
Mono- and di-peg IL-10 production; and uses
|
CN101870728A
(zh)
|
2009-04-23 |
2010-10-27 |
派格生物医药(苏州)有限公司 |
新型Exendin变体及其缀合物
|
RS56496B1
(sr)
|
2009-06-09 |
2018-01-31 |
Prolong Pharmaceuticals Llc |
Kompozicije hemoglobina
|
SG176897A1
(en)
|
2009-06-25 |
2012-01-30 |
Savient Pharmaceuticals Inc |
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
|
WO2011003633A1
(en)
|
2009-07-06 |
2011-01-13 |
Alize Pharma Ii |
Pegylated l-asparaginase
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
CA2770149A1
(en)
|
2009-08-05 |
2011-02-10 |
Pieris Ag |
Controlled release formulations of lipocalin muteins
|
HUE028832T2
(en)
|
2009-09-17 |
2017-01-30 |
Baxalta Inc |
Stable co-formulation of hyaluronidase and immunoglobulin, as well as a process for its preparation
|
US20110081398A1
(en)
*
|
2009-10-01 |
2011-04-07 |
Tyco Healthcare Group Lp |
Multi-mechanism surgical compositions
|
US20110081701A1
(en)
*
|
2009-10-02 |
2011-04-07 |
Timothy Sargeant |
Surgical compositions
|
US8968785B2
(en)
*
|
2009-10-02 |
2015-03-03 |
Covidien Lp |
Surgical compositions
|
CA2784800A1
(en)
|
2009-12-21 |
2011-07-21 |
Ambrx, Inc. |
Modified porcine somatotropin polypeptides and their uses
|
CA2784793A1
(en)
|
2009-12-21 |
2011-07-21 |
Ambrx, Inc. |
Modified bovine somatotropin polypeptides and their uses
|
CA2791841C
(en)
|
2010-03-05 |
2023-01-03 |
Rigshospitalet |
Chimeric inhibitor molecules of complement activation
|
JP2013528374A
(ja)
|
2010-05-10 |
2013-07-11 |
パーシード セラピューティクス リミテッド ライアビリティ カンパニー |
Vla4のポリペプチド阻害剤
|
EP2585093A4
(de)
*
|
2010-06-24 |
2014-01-15 |
Vasculogics Inc |
Zusammensetzungen und verfahren zur behandlung von thrombosen und zur verlängerung der lebensdauer gelagerter thrombozyten
|
JP5825507B2
(ja)
*
|
2010-06-25 |
2015-12-02 |
日油株式会社 |
分岐型ヘテロポリエチレングリコール
|
US10040761B2
(en)
|
2010-06-25 |
2018-08-07 |
Nof Corporation |
Branched hetero polyethylene glycol and intermediate
|
CA2806058C
(en)
|
2010-07-20 |
2016-09-13 |
Halozyme, Inc. |
Adverse side-effects associated with administration of anti-hyaluronan agents and methods for ameliorating or preventing the side-effects
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
RS59193B1
(sr)
|
2010-08-17 |
2019-10-31 |
Ambrx Inc |
Modifikovani polipeptidi relaksina i njihova primena
|
AR083006A1
(es)
|
2010-09-23 |
2013-01-23 |
Lilly Co Eli |
Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
|
WO2012088422A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of taxane-based compounds
|
WO2012088445A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
|
IT1403458B1
(it)
|
2010-12-28 |
2013-10-17 |
Scarpa Calzaturificio Spa |
Scarpone da sci
|
ES2634669T3
(es)
|
2011-02-08 |
2017-09-28 |
Halozyme, Inc. |
Composición y formulación lipídica de una enzima de degradación de hialuronano y uso de la misma para el tratamiento de la hiperplasia benigna de próstata
|
AP2013007173A0
(en)
|
2011-03-16 |
2013-10-31 |
Amgen Inc |
Potent and selective inhibitors of NAV1.3 and NAV1.7
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
US20130011378A1
(en)
|
2011-06-17 |
2013-01-10 |
Tzung-Horng Yang |
Stable formulations of a hyaluronan-degrading enzyme
|
WO2012174480A2
(en)
|
2011-06-17 |
2012-12-20 |
Halozyme, Inc. |
Continuous subcutaneous insulin infusion methods with a hyaluronan degrading enzyme
|
WO2013003593A1
(en)
|
2011-06-28 |
2013-01-03 |
Alternative Innovative Technologies Llc |
Methods of use of hsp70 for increased performance or hsp70 related disorders
|
JP5252036B2
(ja)
*
|
2011-06-28 |
2013-07-31 |
大日本印刷株式会社 |
親水性層を有する基材
|
AU2012280474A1
(en)
|
2011-07-01 |
2014-01-16 |
Bayer Intellectual Property Gmbh |
Relaxin fusion polypeptides and uses thereof
|
PT2717917T
(pt)
|
2011-07-05 |
2016-07-27 |
Bioasis Technologies Inc |
Conjugados de anticorpos p97
|
US9034318B2
(en)
|
2011-08-30 |
2015-05-19 |
The Regents Of The University Of Colorado, A Body Corporate |
Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
|
US20130071394A1
(en)
|
2011-09-16 |
2013-03-21 |
John K. Troyer |
Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and methods of use
|
WO2013056197A1
(en)
|
2011-10-14 |
2013-04-18 |
Alternative Innovative Technologies Llc |
Degradation resistant hsp70 formulations and uses thereof
|
CN104093415B
(zh)
|
2011-10-24 |
2017-04-05 |
哈洛齐梅公司 |
抗乙酰透明质酸剂疗法的同伴诊断剂及其使用方法
|
RU2685867C2
(ru)
|
2011-12-15 |
2019-04-23 |
Алтернатив Инновейтив Текнолоджиз Ллц |
Гибридные белки и белковые конъюгаты на основе белка теплового шока-70 (БТШ70) и способы их применения (варианты)
|
WO2013102144A2
(en)
|
2011-12-30 |
2013-07-04 |
Halozyme, Inc. |
Ph20 polypeptede variants, formulations and uses thereof
|
PT2833905T
(pt)
|
2012-04-04 |
2018-08-06 |
Halozyme Inc |
Terapia de combinação com hialuronidase e um taxano dirigido a tumor
|
MY167814A
(en)
|
2012-04-19 |
2018-09-26 |
Opko Biologics Ltd |
Long-acting oxyntomodulin variants and methods of producing same
|
KR102092025B1
(ko)
|
2012-06-04 |
2020-03-24 |
옵코 바이오로직스 리미티드 |
페길화된 옥신토모둘린 변이체
|
CA2875989A1
(en)
|
2012-06-08 |
2013-12-12 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
DK2863955T3
(en)
|
2012-06-26 |
2017-01-23 |
Sutro Biopharma Inc |
MODIFIED FC PROTEINS, INCLUDING LOCATION-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, CONJUGATES THEREOF, METHODS OF PRODUCING ITS AND PROCEDURES FOR USE THEREOF
|
AU2013296557B2
(en)
|
2012-07-31 |
2019-04-18 |
Bioasis Technologies Inc. |
Dephosphorylated lysosomal storage disease proteins and methods of use thereof
|
HUE045227T2
(hu)
|
2012-08-31 |
2019-12-30 |
Sutro Biopharma Inc |
Azido csoportot tartalmazó módosított aminosavak
|
US9278124B2
(en)
|
2012-10-16 |
2016-03-08 |
Halozyme, Inc. |
Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
|
EP2916835A4
(de)
|
2012-11-12 |
2016-07-27 |
Redwood Bioscience Inc |
Verbindungen und verfahren zur herstellung eines konjugats
|
US9310374B2
(en)
|
2012-11-16 |
2016-04-12 |
Redwood Bioscience, Inc. |
Hydrazinyl-indole compounds and methods for producing a conjugate
|
WO2014078733A1
(en)
|
2012-11-16 |
2014-05-22 |
The Regents Of The University Of California |
Pictet-spengler ligation for protein chemical modification
|
MX363326B
(es)
|
2012-11-20 |
2019-03-20 |
Opko Biologics Ltd |
Metodo para incrementar el volumen hidrodinamico de polipeptidos mediante la union a peptidos carboxi-terminales de gonadotrofina.
|
US20160067347A1
(en)
|
2012-12-20 |
2016-03-10 |
Amgen Inc. |
Apj receptor agonists and uses thereof
|
WO2014110867A1
(zh)
*
|
2013-01-17 |
2014-07-24 |
厦门赛诺邦格生物科技有限公司 |
一种单一官能化的支化聚乙二醇及其修饰的生物相关物质
|
WO2014114262A1
(zh)
*
|
2013-01-28 |
2014-07-31 |
天津键凯科技有限公司 |
水溶性聚合物-氨基酸寡肽-药物结合物及其制备方法和用途
|
US9700633B2
(en)
|
2013-01-28 |
2017-07-11 |
Jenkem Technology Co., Ltd., Tianjin Branch |
Conjugates of water soluble polymer-amino acid oligopeptide-drug, preparation method and use thereof
|
US9675678B2
(en)
|
2013-01-29 |
2017-06-13 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions and methods for treatment of homocystinuria
|
US10279012B2
(en)
|
2013-03-11 |
2019-05-07 |
Healthpartners Research & Education |
Methods of treating and preventing social communication disorder in patients by intranasal administration of insulin
|
TW201446792A
(zh)
|
2013-03-12 |
2014-12-16 |
Amgen Inc |
Nav1.7之強效及選擇性抑制劑
|
NZ711373A
(en)
|
2013-03-13 |
2020-07-31 |
Bioasis Technologies Inc |
Fragments of p97 and uses thereof
|
CN106913865A
(zh)
|
2013-04-18 |
2017-07-04 |
阿尔莫生物科技股份有限公司 |
使用白细胞介素‑10治疗疾病和病症的方法
|
US10364451B2
(en)
|
2013-05-30 |
2019-07-30 |
Duke University |
Polymer conjugates having reduced antigenicity and methods of using the same
|
US10392611B2
(en)
|
2013-05-30 |
2019-08-27 |
Duke University |
Polymer conjugates having reduced antigenicity and methods of using the same
|
ES2688206T3
(es)
|
2013-06-17 |
2018-10-31 |
Armo Biosciences, Inc. |
Procedimiento de evaluación de la identidad y la estabilidad de proteínas
|
TW201534726A
(zh)
|
2013-07-03 |
2015-09-16 |
Halozyme Inc |
熱穩定ph20玻尿酸酶變異體及其用途
|
US9764039B2
(en)
|
2013-07-10 |
2017-09-19 |
Sutro Biopharma, Inc. |
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
MX2016000364A
(es)
|
2013-07-12 |
2016-05-09 |
Ophthotech Corp |
Metodos para tratar o prevenir afecciones oftalmologicas.
|
AU2014312190A1
(en)
|
2013-08-28 |
2016-02-18 |
Bioasis Technologies Inc. |
CNS-targeted conjugates of antibodies
|
EP3038642A4
(de)
|
2013-08-30 |
2017-01-18 |
Armo Biosciences, Inc. |
Verfahren zur verwendung von interleukin-10 zur behandlung von erkrankungen und leiden
|
WO2015054658A1
(en)
|
2013-10-11 |
2015-04-16 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
IL293071A
(en)
|
2013-10-15 |
2022-07-01 |
Seagen Inc |
Polyethylene glycol modified drug-linker for improved ligand-drug conjugated pharmacokinetics
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
AU2014346537A1
(en)
|
2013-11-11 |
2016-05-19 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
US9493413B2
(en)
|
2013-11-27 |
2016-11-15 |
Redwood Bioscience, Inc. |
Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
|
ITTV20130205A1
(it)
|
2013-12-06 |
2015-06-07 |
Scarpa Calzaturificio Spa |
Scarpone da sci
|
ITTV20130204A1
(it)
|
2013-12-06 |
2015-06-07 |
Scarpa Calzaturificio Spa |
Scarpone da sci
|
US10314911B2
(en)
|
2014-04-08 |
2019-06-11 |
Healthpartners Research & Education |
Methods for protecting and treating traumatic brain injury, concussion and brain inflammation with intranasal insulin
|
US10293043B2
(en)
|
2014-06-02 |
2019-05-21 |
Armo Biosciences, Inc. |
Methods of lowering serum cholesterol
|
AU2015274574B2
(en)
|
2014-06-10 |
2019-10-10 |
Amgen Inc. |
Apelin polypeptides
|
HUE043847T2
(hu)
|
2014-08-28 |
2019-09-30 |
Halozyme Inc |
Hialuronán-lebontó enzimmel és egy immun checkpoint inhibitorral végzett kombinációs terápia
|
NZ746680A
(en)
|
2014-10-14 |
2020-07-31 |
Halozyme Inc |
Compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using same
|
KR20170068553A
(ko)
|
2014-10-14 |
2017-06-19 |
아르모 바이오사이언시스 인코포레이티드 |
인터류킨-15 조성물 및 이의 용도
|
KR20170084033A
(ko)
|
2014-10-22 |
2017-07-19 |
아르모 바이오사이언시스 인코포레이티드 |
질환 및 장애를 치료하기 위해 인터루킨-10을 사용하는 방법
|
CN107108711B
(zh)
|
2014-10-23 |
2021-11-23 |
恩格姆生物制药公司 |
包含肽变异体的药物组合物及其使用方法
|
PT3412302T
(pt)
|
2014-10-24 |
2021-06-09 |
Bristol Myers Squibb Co |
Polipéptidos de fgf-21 modificados e utilizações dos mesmos
|
EP4282485A3
(de)
|
2014-11-06 |
2024-01-17 |
PharmaEssentia Corporation |
Dosierungsplan für pegyliertes interferon
|
WO2016126615A1
(en)
|
2015-02-03 |
2016-08-11 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
US10385115B2
(en)
|
2015-03-26 |
2019-08-20 |
Duke University |
Fibronectin type III domain-based fusion proteins
|
CA2986755A1
(en)
|
2015-05-28 |
2016-12-01 |
Armo Biosciences, Inc. |
Pegylated interleukin-10 for use in treating cancer
|
EP3302528A1
(de)
|
2015-05-29 |
2018-04-11 |
Armo Biosciences, Inc. |
Verfahren zur verwendung von interleukin-10 zur behandlung von erkrankungen und leiden
|
KR20180014754A
(ko)
|
2015-05-29 |
2018-02-09 |
옵코 바이오로직스 리미티드 |
페길화된 옥신토모둘린 변이체
|
EA201890020A1
(ru)
|
2015-06-15 |
2018-05-31 |
Зе Боард Оф Трастиз Оф Зе Леланд Стэнфорд Джуниор Юниверсити |
Способы и композиции для лечения ассоциированных со старением состояний
|
KR102172937B1
(ko)
|
2015-06-19 |
2020-11-03 |
옵코 바이오로직스 리미티드 |
장기-작용성 응고 인자 및 그의 제조 방법
|
EP3331557B1
(de)
|
2015-08-04 |
2021-04-07 |
Duke University |
Genetisch codierte intrinsisch ungeordnete stealth-polymere zur freisetzung und verfahren zur verwendung davon
|
MX2018002298A
(es)
|
2015-08-25 |
2018-07-06 |
Armo Biosciences Inc |
Metodos de uso de interleucina 10 para el tratamiento de enfermedades y trastornos.
|
EP3373922B1
(de)
|
2015-11-09 |
2022-01-05 |
The Regents of The University of Colorado, A Body Corporate |
Zusammensetzungen und verfahren zur verwendung zur behandlung von homocystinurie
|
ES2871036T3
(es)
|
2015-11-09 |
2021-10-28 |
Ngm Biopharmaceuticals Inc |
Método para el tratamiento de trastornos relacionados con ácidos biliares
|
US11793880B2
(en)
|
2015-12-04 |
2023-10-24 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
AU2016363013B2
(en)
|
2015-12-04 |
2022-03-10 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
US20190015520A1
(en)
*
|
2015-12-21 |
2019-01-17 |
Duke University |
Polymer conjugates having reduced antigenicity and methods of using the same
|
ITUB20160158A1
(it)
|
2016-01-15 |
2017-07-15 |
Scarpa Calzaturificio Spa |
Scarpone da sci
|
WO2017160599A1
(en)
|
2016-03-14 |
2017-09-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of cd300b antagonists to treat sepsis and septic shock
|
WO2017165851A1
(en)
|
2016-03-25 |
2017-09-28 |
Seattle Genetics, Inc. |
Process for the preparation of pegylated drug-linkers and intermediates thereof
|
US10421785B2
(en)
|
2016-04-11 |
2019-09-24 |
Bar-Ilan University |
Delta receptor agonist peptides and use thereof
|
WO2017210476A1
(en)
|
2016-06-01 |
2017-12-07 |
Duke University |
Nonfouling biosensors
|
US20190160152A1
(en)
|
2016-06-09 |
2019-05-30 |
Opko Biologics Ltd. |
Long-acting oxyntomodulin formulation and methods of producing and administering same
|
EP3512868A4
(de)
|
2016-09-14 |
2020-04-15 |
Duke University |
Triblock-polypeptid-basierte nanopartikel zur abgabe von hydrophilen arzneimitteln
|
JP2020500150A
(ja)
|
2016-09-23 |
2020-01-09 |
デューク ユニバーシティ |
下限臨界溶液温度挙動を有する非反復かつ非構造的ポリペプチド
|
CA3039311A1
(en)
|
2016-10-07 |
2018-04-12 |
Tokyo Institute Of Technology |
Branched type hetero monodispersed polyethylene glycol, production method thereof, and conjugate thereof
|
CN116143678A
(zh)
|
2016-11-14 |
2023-05-23 |
杭州多禧生物科技有限公司 |
偶联连接体,含有此连接体的细胞结合分子-药物偶联物及其制备和应用
|
US11135307B2
(en)
|
2016-11-23 |
2021-10-05 |
Mersana Therapeutics, Inc. |
Peptide-containing linkers for antibody-drug conjugates
|
WO2018132732A1
(en)
|
2017-01-12 |
2018-07-19 |
Duke University |
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
|
CN110637027A
(zh)
|
2017-02-08 |
2019-12-31 |
百时美施贵宝公司 |
包含药代动力学增强子的修饰的松弛素多肽及其用途
|
AU2018237683A1
(en)
|
2017-03-24 |
2019-10-31 |
Seagen Inc. |
Process for the preparation of glucuronide drug-linkers and intermediates thereof
|
JP6935059B2
(ja)
|
2017-03-30 |
2021-09-15 |
日油株式会社 |
カルボキシル基を一つ有するポリエチレングリコールの精製方法
|
AU2018254410A1
(en)
|
2017-04-17 |
2019-10-10 |
The Regents Of The University Of Colorado, A Body Corporate |
Optimization of enzyme replacement therapy for treatment of homocystinuria
|
WO2018213320A1
(en)
|
2017-05-15 |
2018-11-22 |
Duke University |
Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
|
BR112019027583A2
(pt)
|
2017-06-22 |
2020-10-06 |
Catalyst Biosciences, Inc. |
polipeptídeos de serina protease 1 tipo membrana (mtsp-1) modificados e métodos de uso
|
US11680083B2
(en)
|
2017-06-30 |
2023-06-20 |
Duke University |
Order and disorder as a design principle for stimuli-responsive biopolymer networks
|
CN111315398A
(zh)
|
2017-11-10 |
2020-06-19 |
阿尔莫生物科技股份有限公司 |
白介素-10与免疫检查点途径抑制剂的组合的组合物和使用方法
|
EP3732254A4
(de)
|
2017-12-26 |
2021-12-22 |
Becton, Dickinson and Company |
Tiefe uv-erregbare wassersolvatisierte polymerfarbstoffe
|
US10844228B2
(en)
|
2018-03-30 |
2020-11-24 |
Becton, Dickinson And Company |
Water-soluble polymeric dyes having pendant chromophores
|
WO2019211842A1
(en)
|
2018-04-30 |
2019-11-07 |
Opko Biologics Ltd. |
Long-acting human growth hormone-antagonists and methods of producing the same
|
WO2019222435A1
(en)
|
2018-05-16 |
2019-11-21 |
Halozyme, Inc. |
Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
|
CN112533629A
(zh)
|
2018-06-19 |
2021-03-19 |
阿尔莫生物科技股份有限公司 |
结合使用il-10药剂与嵌合抗原受体细胞疗法的组合物和方法
|
CA3107332A1
(en)
|
2018-07-22 |
2020-01-30 |
Bioasis Technologies Inc. |
Treatment of lymphatic metastases
|
WO2020028806A1
(en)
|
2018-08-02 |
2020-02-06 |
Duke University |
Dual agonist fusion proteins
|
SG11202102427XA
(en)
|
2018-09-11 |
2021-04-29 |
Ambrx Inc |
Interleukin-2 polypeptide conjugates and their uses
|
CN110964116A
(zh)
|
2018-09-26 |
2020-04-07 |
北京辅仁瑞辉生物医药研究院有限公司 |
GLP1-Fc融合蛋白及其缀合物
|
EP3867265A1
(de)
|
2018-10-19 |
2021-08-25 |
Ambrx, Inc. |
Interleukin-10 -polypeptid-konjugate, dimere davon und ihre verwendungen
|
WO2020140101A1
(en)
|
2018-12-28 |
2020-07-02 |
Catalyst Biosciences, Inc. |
Modified urokinase-type plasminogen activator polypeptides and methods of use
|
US11613744B2
(en)
|
2018-12-28 |
2023-03-28 |
Vertex Pharmaceuticals Incorporated |
Modified urokinase-type plasminogen activator polypeptides and methods of use
|
CN113710692A
(zh)
|
2019-02-11 |
2021-11-26 |
Opko生物科学有限公司 |
长效glp-2类似物
|
WO2020168017A1
(en)
|
2019-02-12 |
2020-08-20 |
Ambrx, Inc. |
Compositions containing, methods and uses of antibody-tlr agonist conjugates
|
US10882954B2
(en)
|
2019-04-11 |
2021-01-05 |
Sunbio Inc. |
Tertiary alkoxy polyethylene glycol and derivatives thereof
|
CN112175088B
(zh)
|
2019-07-02 |
2023-03-28 |
江苏晟斯生物制药有限公司 |
改进的fix融合蛋白、缀合物及其应用
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
CN115551530A
(zh)
|
2019-08-27 |
2022-12-30 |
通尼克斯制药有限公司 |
经修饰的tff2多肽
|
WO2021183832A1
(en)
|
2020-03-11 |
2021-09-16 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and methods of use thereof
|
US20210355468A1
(en)
|
2020-05-18 |
2021-11-18 |
Bioasis Technologies, Inc. |
Compositions and methods for treating lewy body dementia
|
US20210393787A1
(en)
|
2020-06-17 |
2021-12-23 |
Bioasis Technologies, Inc. |
Compositions and methods for treating frontotemporal dementia
|
CA3128035A1
(en)
|
2020-08-13 |
2022-02-13 |
Bioasis Technologies, Inc. |
Combination therapies for delivery across the blood brain barrier
|
EP4199968A1
(de)
|
2020-08-20 |
2023-06-28 |
Ambrx, Inc. |
Antikörper-tlr-agonist-konjugate, verfahren und verwendungen davon
|
US11952461B2
(en)
|
2021-03-22 |
2024-04-09 |
Sunbio, Inc. |
Siloxy polyethylene glycol and derivatives thereof
|
US20220313798A1
(en)
|
2021-03-30 |
2022-10-06 |
Jazz Pharmaceuticals Ireland Ltd. |
Dosing of recombinant l-asparaginase
|
CA3213805A1
(en)
|
2021-04-03 |
2022-10-06 |
Feng Tian |
Anti-her2 antibody-drug conjugates and uses thereof
|
EP4155349A1
(de)
|
2021-09-24 |
2023-03-29 |
Becton, Dickinson and Company |
Wasserlösliche gelbe grünabsorbierende farbstoffe
|
WO2024007016A2
(en)
|
2022-07-01 |
2024-01-04 |
Beckman Coulter, Inc. |
Novel fluorescent dyes and polymers from dihydrophenanthrene derivatives
|
WO2024015529A2
(en)
|
2022-07-14 |
2024-01-18 |
Jazz Pharmaceuticals Ireland Ltd. |
Combination therapies involving l-asparaginase
|
WO2024044327A1
(en)
|
2022-08-26 |
2024-02-29 |
Beckman Coulter, Inc. |
Dhnt monomers and polymer dyes with modified photophysical properties
|